ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Research Associate, Preclinical Pharmacology at Nurix - ApplyBlast

Senior Research Associate, Preclinical Pharmacology

Nurix

6 days ago

3.9 on Glassdoor

Brisbane, California, United States

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

This role involves executing in vivo studies, including mouse efficacy, PK/PD, and mechanism-of-action research in oncology and inflammation models. The position requires generating Western blot and flow cytometry data to demonstrate how targeted protein degradation molecules function. The role supports the advancement of degrader programs toward clinical development through hands-on laboratory and animal facility work.

Responsibilities

Execute in vivo efficacy and PK/PD studies in oncology and inflammation models
Perform Western blotting and flow cytometry to analyze target degradation and immune phenotyping
Handle mice and conduct dosing, blood collection, and tissue harvest procedures

Skills

Qualifications

BS in BiologyBS in PharmacologyBS in ImmunologyBS in Cancer BiologyMS in Biology

About Nurix

nurixtx.com

Headquarters

Brisbane, California, United States

Company Size

201-500 employees

Founded

2012

View Profile

Nurix Therapeutics is a clinical-stage biopharmaceutical company developing medicines that harness targeted protein degradation to treat cancer and autoimmune diseases. Using a proprietary platform that combines small-molecule degraders and Degradation Activating Compounds (DACs) to engage E3 ubiquitin ligases and the ubiquitin–proteasome system, Nurix aims to selectively remove disease-causing proteins. The company advances multiple discovery and development programs and collaborates with partners to translate its platform into novel therapies. Their mission, "Medicines to Outmatch Disease," guides efforts to create differentiated, targeted treatments.